| Name | Title | Contact Details |
|---|
Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.
Hyperfine`s mission is to make MRI accessible to every patient, regardless of income or resources. Anytime. Anywhere. Hyperfine designed the Swoop™ Portable MR Imaging System to overcome patient transport and dedicated room requirements associated with fixed conventional MRI systems. The Swoop™ system plugs into a standard electrical outlet, uses an Apple iPad® for control, and produces images at a patient`s bedside within minutes, allowing care teams to gain clinical information quickly. Fierce Medtech recently recognized Hyperfine as a 2020 Fierce 15 company for its innovative and creative approach to developing solutions for healthcare providers and patients. Hyperfine is part of 4Catalyzer, a portfolio of health technology companies with facilities in Connecticut, New York City, Palo Alto, California, and Taiwan.
For more than 50 years, Younger Optics has established itself as a leader in the optical industry by developing new and innovative lens solutions. From polarized sun lenses that block blinding glare to lenses designed specifically for the driving task -
Heartland Optical Inc is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sysmex America, Inc. distributes and supports automated `in vitro` diagnostic hematology, coagulation and urinalysis analyzers, reagents, and information systems for laboratories and healthcare facilities throughout the Western Hemisphere.? The company was formerly known as Sysmex Corporation Of America and changed its name to Sysmex America, Inc. in June 2003. The company was founded in 1979 and is based in Lincolnshire, Illinois. Sysmex America, Inc. operates as a subsidiary of Sysmex Corp.